247 related articles for article (PubMed ID: 9369420)
41. Death of solid tumor cells induced by Fas ligand expressing primary myoblasts.
Hofmann A; Blau HM
Somat Cell Mol Genet; 1997 Jul; 23(4):249-57. PubMed ID: 9542527
[TBL] [Abstract][Full Text] [Related]
42. Increased oxidant-induced apoptosis in cultured nondividing human retinal pigment epithelial cells.
Jiang S; Moriarty SE; Grossniklaus H; Nelson KC; Jones DP; Sternberg P
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2546-53. PubMed ID: 12147583
[TBL] [Abstract][Full Text] [Related]
43. Expression of Fas (CD95) and FasL (CD95L) in human airway epithelium.
Hamann KJ; Dorscheid DR; Ko FD; Conforti AE; Sperling AI; Rabe KF; White SR
Am J Respir Cell Mol Biol; 1998 Oct; 19(4):537-42. PubMed ID: 9761749
[TBL] [Abstract][Full Text] [Related]
44. Fas-fas ligand system-induced apoptosis in human placenta and gestational trophoblastic disease.
Mor G; Gutierrez LS; Eliza M; Kahyaoglu F; Arici A
Am J Reprod Immunol; 1998 Aug; 40(2):89-94. PubMed ID: 9764350
[TBL] [Abstract][Full Text] [Related]
45. Regulation of Fas and Fas ligand expression in cultured murine renal cells and in the kidney during endotoxemia.
Ortiz-Arduan A; Danoff TM; Kalluri R; González-Cuadrado S; Karp SL; Elkon K; Egido J; Neilson EG
Am J Physiol; 1996 Dec; 271(6 Pt 2):F1193-201. PubMed ID: 8997393
[TBL] [Abstract][Full Text] [Related]
46. IL-18, a product of choriodecidual cells, increases during premature rupture of membranes but fails to turn on the Fas-FasL-mediated apoptosis pathway.
Menon R; Lombardi SJ; Fortunato SJ
J Assist Reprod Genet; 2001 May; 18(5):276-84. PubMed ID: 11464579
[TBL] [Abstract][Full Text] [Related]
47. Co-expression of Fas (APO-1, CD95)/Fas ligand by BeWo and NJG choriocarcinoma cell lines.
Rajashekhar G; Loganath A; Roy AC; Mongelli JM
Gynecol Oncol; 2003 Oct; 91(1):101-11. PubMed ID: 14529668
[TBL] [Abstract][Full Text] [Related]
48. Fas ligand expression in nodal non-Hodgkin's lymphoma.
Müllauer L; Mosberger I; Chott A
Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
[TBL] [Abstract][Full Text] [Related]
49. Fas ligand expression in Hodgkin lymphoma.
Verbeke CS; Wenthe U; Grobholz R; Zentgraf H
Am J Surg Pathol; 2001 Mar; 25(3):388-94. PubMed ID: 11224610
[TBL] [Abstract][Full Text] [Related]
50. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand.
Shurin GV; Gerein V; Lotze MT; Barksdale EM
Nat Immun; 1998; 16(5-6):263-74. PubMed ID: 11061594
[TBL] [Abstract][Full Text] [Related]
51. Fas and Fas ligand expression in tumor cells and in vascular smooth-muscle cells of colonic and renal carcinomas.
Peduto Eberl L; Guillou L; Saraga E; Schröter M; French LE; Tschopp J; Juillerat-Jeanneret L
Int J Cancer; 1999 May; 81(5):772-8. PubMed ID: 10328232
[TBL] [Abstract][Full Text] [Related]
52. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
53. Ex vivo malignant glioma cells are sensitive to Fas (CD95/APO-1) ligand-mediated apoptosis.
Frei K; Ambar B; Adachi N; Yonekawa Y; Fontana A
J Neuroimmunol; 1998 Jul; 87(1-2):105-13. PubMed ID: 9670851
[TBL] [Abstract][Full Text] [Related]
54. Functional expression of Fas and Fas ligand on human intestinal intraepithelial lymphocytes.
Morimoto Y; Hizuta A; Ding EX; Ishii T; Hongo T; Fujiwara T; Iwagaki H; Tanaka N
Clin Exp Immunol; 1999 Apr; 116(1):84-9. PubMed ID: 10209509
[TBL] [Abstract][Full Text] [Related]
55. Interaction of Fas ligand and Fas expressed on osteoclast precursors increases osteoclastogenesis.
Park H; Jung YK; Park OJ; Lee YJ; Choi JY; Choi Y
J Immunol; 2005 Dec; 175(11):7193-201. PubMed ID: 16301623
[TBL] [Abstract][Full Text] [Related]
56. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
Kalas W; Matuszyk J; Ziolo E; Strzadala L
Anticancer Res; 2003; 23(2B):1613-7. PubMed ID: 12820430
[TBL] [Abstract][Full Text] [Related]
57. The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell J; O'Sullivan GC; Collins JK; Shanahan F
J Exp Med; 1996 Sep; 184(3):1075-82. PubMed ID: 9064324
[TBL] [Abstract][Full Text] [Related]
58. Interleukin-12 enhances the sensitivity of human osteosarcoma cells to 4-hydroperoxycyclophosphamide by a mechanism involving the Fas/Fas-ligand pathway.
Duan X; Zhou Z; Jia SF; Colvin M; Lafleur EA; Kleinerman ES
Clin Cancer Res; 2004 Jan; 10(2):777-83. PubMed ID: 14760101
[TBL] [Abstract][Full Text] [Related]
59. CD4+ cells play a major role in xenogeneic human anti-pig cytotoxicity through the Fas/Fas ligand lytic pathway.
Yi S; Feng X; Wang Y; Kay TW; Wang Y; O'Connell PJ
Transplantation; 1999 Feb; 67(3):435-43. PubMed ID: 10030292
[TBL] [Abstract][Full Text] [Related]
60. Expressions of Fas/DcR3 and RGD-FasL mediated apoptosis in pituitary adenomas.
Chen L; Tian X; Li W; Agarwal A; Zhuang G
Neurol India; 2009; 57(1):28-30. PubMed ID: 19305072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
